Paclitaxel

پاکلی‌تاکسل

⚠ Unverified

🎗️ Antineoplastic And Immunomodulating AgentsTaxane

Market / country: 🇺🇸 USA

Taxol (US)

🧮 Dose calculator

Ovarian cancer · Regimen source: FDA Paclitaxel · Dosage and Administration

  • • Or 135 mg/m² over 24 h. Premedicate: dexamethasone 20 mg PO 12 and 6 h before, diphenhydramine 50 mg and cimetidine 300 mg IV 30–60 min before. Non-PVC sets. FDA Paclitaxel · Dosage and Administration
  • • Only under an oncologist in an equipped centre. Calculator = label mg/m² × BSA (Mosteller); protocol, cycle interval and adjustment for CBC and renal/hepatic function rest with the oncology team. FDA Paclitaxel · Dosage and Administration

Enter age and weight.

🛡️ Safety & information

Contraindications

  • ⛔ History of hypersensitivity to paclitaxel or polyoxyl 35 castor oil drugs; baseline neutrophils <1,500 (solid tumours) or <1,000 (Kaposi sarcoma). FDA Paclitaxel · Contraindications

Warnings

  • • Boxed warning: anaphylaxis and severe hypersensitivity (fatal despite premedication); myelosuppression — not with neutrophils <1,500. FDA Paclitaxel · Warnings

Formulations

👥 Special populations

  • 🤰 PregnancyDangerous / avoid

    Label: can cause fetal harm. Dangerous in pregnancy. FDA Paclitaxel · Pregnancy

    “Paclitaxel injection can cause fetal harm when administered to a pregnant woman.”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Paclitaxel · Nursing Mothers

    “Following intravenous administration of carbon 14 labeled paclitaxel to rats on days 9 to 10 postpartum, concentrations of radioactivity in milk were higher than in plasma and declined in parallel with the plasma concentrations.”
  • 👶 ChildrenSafety not established

    Label: safety and effectiveness in children have not been established. FDA Paclitaxel · Pediatric Use

    “The safety and effectiveness of paclitaxel injection in pediatric patients have not been established.”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Paclitaxel · Geriatric Use

    “Of 2228 patients who received paclitaxel in 8 clinical studies evaluating its safety and effectiveness in the treatment of advanced ovarian cancer, breast carcinoma, or NSCLC, and 1570 patients who were randomized to receive paclitaxel in the adjuvant breast cancer study, 649 patients (17%) were 65 years or older and …”
  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Same class

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav